TenderlineUK
Procurement Intelligence
Official OCDS
Find a Tender
complete
Official procurement procedure

NHS Framework Agreement for the supply of Adult Influenza Vaccines – Secondary Care

Influenza vaccines
UK
Published value
Not published
Submission deadline Not published
Lots published5
Procurement Executive Summary
AI & Search Synopsis
Generated from official OCDS record
Tenderline Synopsis: The NHS Commissioning Board (operating under the name of NHS England): "NHS Framework Agreement for the supply of Adult Influenza Vaccines – Secondary Care". Published status: complete. Published value: Value not published. 5 published lots. Submission deadline not published. See the official notice for participation instructions.
Contracting AuthorityThe NHS Commissioning Board (operating under the name of NHS England)Scope & CategoriesNot publishedSubmission Window
complete
No deadline published
Submission GatewayDirect notice routeLegal Basis & RegimeStandard procurementEstimated Value (exc. VAT)Not published
Bidder Intelligence · Authority Profile: The NHS Commissioning Board (operating under the name of NHS England)
Market Analytics
View Authority Profile →
Derived from OCDS awards & bid statistics
Published history for The NHS Commissioning Board (operating under the name of NHS England). These figures describe retained records, not a forecast of bids or a measure of buyer bias.
Published-to-award variance
Not availableInsufficient comparable data
Requires at least 5 comparable procedures
Competition Density
46Bids / Report
1.7% of reports have one bid
Supplier ConcentrationNo estimate
Insufficient attributable awardsNo concentration estimate available
Payment Terms
Check noticePublished terms
Payment obligations depend on the applicable regime and contract. Consult the official documents.
Coverage: 829 active published awards; 827 bid reports (which may be per lot). Supplier values exclude multi-supplier awards, frameworks and DPS, and use GBP only. They are published award values, not payments. Published-to-award variance compares single-lot, single-award, single-supplier GBP procedures with explicitly non-framework/non-DPS status; increases remain in the average. Unpublished data stays unknown. Awarded suppliers are winners, not all bidders.
Procedure terms
Contracting AuthorityThe NHS Commissioning Board (operating under the name of NHS England)
Procedure methodNot published
Procurement categoryNot published
Statuscomplete
Framework / DPSFramework
CompetitionNot published
Above thresholdNot published
Legal basisNot published
Tender period startsNot published
Clarification deadlineNot published
Electronic submissionNot published
Submission languagesNot published
Published8 Sept 2021, 15:50 BST
Last source update8 Sept 2021, 15:50 BST
Recurring procurementNot published
ClassificationInfluenza vaccines
Delivery area
UK
OCIDocds-h6vhtk-02aa9d
What is being bought
NHS Framework Agreement for the supply of Adult Influenza Vaccines – Secondary Care. Period of framework agreement: 1 September 2021 to 31 August 2022 with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 36 months. Total maximum framework agreement including extension options will be no more than 48 months . Please refer to the invitation to offer documents for a list of the purchasing points.
What changed
From the official release history
  1. tender value changed
    8 Sept 2021, 15:50 BST
  2. Status changed to complete
    8 Sept 2021, 15:50 BST
  3. Official notice release published
    8 Sept 2021, 15:50 BST
  4. Submission deadline changed to published date
    8 Sept 2021, 15:50 BST
  5. Published value updated to £29,200,000
    27 Apr 2021, 13:03 BST
  6. Status changed to active
    27 Apr 2021, 13:03 BST
  7. Official notice release published
    27 Apr 2021, 13:03 BST
  8. Submission deadline changed to 2 Jun 2021, 13:00 BST
    27 Apr 2021, 13:03 BST
  9. Buyer information updated
    27 Apr 2021, 13:03 BST
Lots and requirements (5)
Published by the contracting authority
  • Lot 1 · #1
    Lot 1 - aQIV
    cancelled
    Published valueNot published
    NHS Framework Agreement for the supply of Adult Influenza Vaccines for Secondary Care. The framework will commence on 1 September 2021 for a period of 12 months, with an option or options to extend (at the Authority's discretion) for a period or periods up to36 months. Total maximum framework agreement including extension options will be no more than 48 months. Please refer to the offer documents for the list of purchasing points
    Contract periodNot published
    EligibilityNot published
    Options / renewalNot published
  • Lot 2 · #2
    Lot 2 - QIV-HD
    cancelled
    Published valueNot published
    NHS Framework Agreement for the supply of Adult Influenza Vaccines for Secondary Care. The framework will commence on 1 September 2021 for a period of 12 months, with an option or options to extend (at the Authority's discretion) for a period or periods upto36 months. Total maximum framework agreement including extension options will be no more than 48 months. Please refer to the offer documents for the list of purchasing points
    Contract periodNot published
    EligibilityNot published
    Options / renewalNot published
  • Lot 3 · #3
    Lot 3 - QIVc
    cancelled
    Published valueNot published
    NHS Framework Agreement for the supply of Adult Influenza Vaccines for Secondary Care. The framework will commence on 1 September 2021 for a period of 12 months, with an option or options to extend (at the Authority's discretion) for a period or periods upto36 months. Total maximum framework agreement including extension options will be no more than 48 months. Please refer to the offer documents for the list of purchasing points
    Contract periodNot published
    EligibilityNot published
    Options / renewalNot published
  • Lot 4 · #4
    Lot 4 - QIVr
    cancelled
    Published valueNot published
    NHS Framework Agreement for the supply of Adult Influenza Vaccines for Secondary Care. The framework will commence on 1 September 2021 for a period of 12 months, with an option or options to extend (at the Authority's discretion) for a period or periods upto36 months. Total maximum framework agreement including extension options will be no more than 48 months. Please refer to the offer documents for the list of purchasing points
    Contract periodNot published
    EligibilityNot published
    Options / renewalNot published
  • Lot 5 · #5
    Lot 5 - QIVe
    cancelled
    Published valueNot published
    NHS Framework Agreement for the supply of Adult Influenza Vaccines for Secondary Care. The framework will commence on 1 September 2021 for a period of 12 months, with an option or options to extend (at the Authority's discretion) for a period or periods up to 36 months. Total maximum framework agreement including extension options will be no more than 48 months. Please refer to the offer documents for the list of purchasing points
    Contract periodNot published
    EligibilityNot published
    Options / renewalNot published
Timeline
  1. Procedure published
    8 Sept 2021, 15:50 BST
  2. Award unsuccessful
    Not published · Not published
  3. Award active
    Not published · Not published
  4. Award active
    Not published · Not published
  5. Award active
    Not published · Not published
  6. Award active
    Not published · Not published
  7. Contract active
    Signed 18 Aug 2021, 00:00 BST · Not published
  8. Contract active
    Signed 18 Aug 2021, 00:00 BST · Not published
  9. Contract active
    Signed 18 Aug 2021, 00:00 BST · Not published
  10. Contract active
    Signed 18 Aug 2021, 00:00 BST · Not published
Commercial outcome and competition
Awards
Awarded supplier not published
Not published · Not published · unsuccessful
Seqirus UK Limited
Not published · Not published · active
Seqirus UK Limited
Not published · Not published · active
Aventis Pharma ltd t/a Sanofi
Not published · Not published · active
Aventis Pharma ltd t/a Sanofi
Not published · Not published · active
Contracts
aQIV
Not published · signed 18 Aug 2021, 00:00 BST · active
QIVc
Not published · signed 18 Aug 2021, 00:00 BST · active
QIVr
Not published · signed 18 Aug 2021, 00:00 BST · active
QIVe
Not published · signed 18 Aug 2021, 00:00 BST · active
Bid statistics
bids: 2 (lot 1)
electronicBids: 2 (lot 1)
foreignBidsFromEU: 2 (lot 1)
foreignBidsFromNonEU: 0 (lot 1)
highestValidBidValue: 1 (lot 1)
lowestValidBidValue: 1 (lot 1)
smeBids: 0 (lot 1)
bids: 2 (lot 3)
electronicBids: 2 (lot 3)
foreignBidsFromEU: 2 (lot 3)
foreignBidsFromNonEU: 0 (lot 3)
highestValidBidValue: 1 (lot 3)
lowestValidBidValue: 1 (lot 3)
smeBids: 0 (lot 3)
bids: 2 (lot 4)
electronicBids: 2 (lot 4)
foreignBidsFromEU: 2 (lot 4)
foreignBidsFromNonEU: 0 (lot 4)
highestValidBidValue: 1 (lot 4)
lowestValidBidValue: 1 (lot 4)
smeBids: 0 (lot 4)
bids: 2 (lot 5)
electronicBids: 2 (lot 5)
foreignBidsFromEU: 2 (lot 5)
foreignBidsFromNonEU: 0 (lot 5)
highestValidBidValue: 1 (lot 5)
lowestValidBidValue: 1 (lot 5)
smeBids: 0 (lot 5)
Buyer and organisations in this procedure

The NHS Commissioning Board (operating under the name of NHS England)

Contracting authority GB-FTS-2505
View buyer profile

  • The NHS Commissioning Board (operating under the name of NHS England)
    buyer
    centralPurchasingBody

    2nd Floor, Rutland House, Runcorn, UK, WA7 2ES
    philip.grieve@nhs.net

  • Aventis Pharma ltd t/a Sanofi
    supplier

    410 Thames Valley, Park Drive, Reading, Reading, UK, RG6 1PT

  • Seqirus UK Limited
    supplier

    Point, 29 Market Street, Maidenhead, UK, SL6 8AA

  • The High Court
    reviewBody

    Strand, London, WC2A 2LL
    generaloffice@administrativecourtoffice.justice.gov.uk
Documents (0)
Official links; attachments are not copied
No data
No linked documents are published
Related procedures (0)
No data
No related procedures published